Yunqi capital, one of staar surgical company's largest shareholders, reiterates its opposition to the proposed merger with alcon

Hong kong--(business wire)--yunqi capital limited (together with its affiliates and the funds it advises, “yunqi capital”), an investment management firm and 5.1% shareholder of staar surgical company (“staar” or the “company”) (nasdaq:staa), today released the following open letter reiterating its opposition to the proposed sale to alcon inc. (six/nyse:alc) on the terms announced on august 5, 2025. october 7, 2025 dear fellow staar surgical shareholders: after reviewing the recent public commu.
ALC Ratings Summary
ALC Quant Ranking